Compile Data Set for Download or QSAR
Report error Found 51 Enz. Inhib. hit(s) with all data for entry = 50008604
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075263((1-{2-[2-(4-Bromo-2-methoxymethyl-phenoxymethyl)-b...)
Affinity DataKi:  11nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075260(5-Bromo-2-{3-[2-(4-dimethylamino-piperidin-1-yl)-e...)
Affinity DataKi:  13nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075231((5-Bromo-2-{3-[2-(4-dimethylamino-piperidin-1-yl)-...)
Affinity DataKi:  15nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075231((5-Bromo-2-{3-[2-(4-dimethylamino-piperidin-1-yl)-...)
Affinity DataKi:  15nMAssay Description:Ability to displace [125I]pPYY from AV12 cell line stably transfected with cloned human neuropeptide Y receptor type 1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075256((1-{2-[2-(2-Bromo-4-methyl-phenoxymethyl)-benzo[b]...)
Affinity DataKi:  78nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075227((1-{2-[2-(2,4-Dibromo-phenoxymethyl)-benzo[b]thiop...)
Affinity DataKi:  120nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075267((1-{2-[2-(2,4-Dimethyl-phenoxymethyl)-benzo[b]thio...)
Affinity DataKi:  120nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075228((1-{2-[2-(2,4-Dichloro-phenoxymethyl)-benzo[b]thio...)
Affinity DataKi:  140nMAssay Description:Ability to displace [125I]pPYY from AV12 cell line stably transfected with cloned human neuropeptide Y receptor type 1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075261((1-{2-[2-(4-Bromo-phenoxymethyl)-benzo[b]thiophen-...)
Affinity DataKi:  160nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075254(5-Bromo-2-{3-[2-(4-dimethylamino-piperidin-1-yl)-e...)
Affinity DataKi:  172nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075242((3-Bromo-4-{3-[2-(4-dimethylamino-piperidin-1-yl)-...)
Affinity DataKi:  190nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075253((1-{2-[2-(4-Chloro-phenoxymethyl)-benzo[b]thiophen...)
Affinity DataKi:  310nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075226(Dimethyl-{1-[2-(2-p-tolyloxymethyl-benzo[b]thiophe...)
Affinity DataKi:  370nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075257((1-{2-[2-(2-Iodo-phenoxymethyl)-benzo[b]thiophen-3...)
Affinity DataKi:  380nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075234(3-Bromo-4-{3-[2-(4-dimethylamino-piperidin-1-yl)-e...)
Affinity DataKi:  380nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075239((1-{2-[2-(4-Bromo-2-methyl-phenoxymethyl)-benzo[b]...)
Affinity DataKi:  420nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075258(Dimethyl-{1-[2-(2-o-tolyloxymethyl-benzo[b]thiophe...)
Affinity DataKi:  420nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075268((2-{3-[2-(4-Dimethylamino-piperidin-1-yl)-ethyl]-b...)
Affinity DataKi:  450nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075233((1-{2-[2-(2-Bromo-phenoxymethyl)-benzo[b]thiophen-...)
Affinity DataKi:  450nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075251((1-{2-[2-(4-Bromo-2-methylaminomethyl-phenoxymethy...)
Affinity DataKi:  660nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075238((1-{2-[2-(2,4-Dichloro-phenoxymethyl)-benzo[b]thio...)
Affinity DataKi:  690nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075252((1-{2-[2-(4-Bromo-2-trifluoromethyl-phenoxymethyl)...)
Affinity DataKi:  720nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075241(Dimethyl-(1-{2-[2-(4-trifluoromethyl-phenoxymethyl...)
Affinity DataKi:  740nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075240((1-{2-[2-(2-Allyl-phenoxymethyl)-benzo[b]thiophen-...)
Affinity DataKi:  980nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075266(Dimethyl-{1-[2-(2-phenoxymethyl-benzo[b]thiophen-3...)
Affinity DataKi:  1.26E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075255([1-(2-{2-[(2,4-Dichloro-phenylamino)-methyl]-benzo...)
Affinity DataKi:  1.70E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075265([1-(2-{2-[1-(2,4-Dichloro-phenoxy)-ethyl]-benzo[b]...)
Affinity DataKi:  1.70E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075232(1-{2-[2-(4-Chloro-phenoxymethyl)-benzo[b]thiophen-...)
Affinity DataKi:  1.90E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075244(3-[2-(4-Dimethylamino-piperidin-1-yl)-ethyl]-benzo...)
Affinity DataKi:  2.30E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075264(Dimethyl-(1-{2-[2-(2,4,6-trimethyl-phenoxymethyl)-...)
Affinity DataKi:  2.42E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075249((1-{2-[2-(4-Bromo-2-dimethylaminomethyl-phenoxymet...)
Affinity DataKi:  2.43E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075243(1-{3-[2-(4-Chloro-phenoxymethyl)-benzo[b]thiophen-...)
Affinity DataKi:  2.60E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075259(2-{3-[2-(4-Dimethylamino-piperidin-1-yl)-ethyl]-be...)
Affinity DataKi:  2.76E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075248([1-(2-{2-[2-(2,4-Dichloro-phenoxy)-ethyl]-benzo[b]...)
Affinity DataKi:  2.80E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075235((1-{2-[2-(2-tert-Butyl-4-methyl-phenoxymethyl)-ben...)
Affinity DataKi:  2.83E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075229(Dimethyl-(1-{2-[2-(2,4,6-tribromo-phenoxymethyl)-b...)
Affinity DataKi:  3.60E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075237((1-{2-[2-(Biphenyl-4-yloxymethyl)-benzo[b]thiophen...)
Affinity DataKi:  3.70E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075245((2,4-Dichloro-phenyl)-{3-[2-(4-dimethylamino-piper...)
Affinity DataKi:  3.80E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075225([1-(2-{2-[(2,4-Dichloro-phenyl)-methoxy-methyl]-be...)
Affinity DataKi:  4.00E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075224((1-{2-[2-(2,4-Dichloro-benzyl)-benzo[b]thiophen-3-...)
Affinity DataKi:  4.20E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075250([1-(2-{2-[(2,4-Dichloro-phenyl)-hydrazonomethyl]-b...)
Affinity DataKi:  4.50E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075228((1-{2-[2-(2,4-Dichloro-phenoxymethyl)-benzo[b]thio...)
Affinity DataKi:  4.70E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075269((2,4-Dichloro-phenyl)-{3-[2-(4-dimethylamino-piper...)
Affinity DataKi:  5.60E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075223([1-(2-{2-[(2,4-Dichloro-phenoxy)-phenyl-methyl]-be...)
Affinity DataKi:  5.80E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075246((1-{2-[2-(2,4-Dichloro-phenyl)-benzo[b]thiophen-3-...)
Affinity DataKi:  6.50E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075262((1-{2-[2-(2,4-Dichloro-phenylethynyl)-benzo[b]thio...)
Affinity DataKi:  7.90E+3nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075222(1-[2-(4-Chloro-phenoxymethyl)-benzo[b]thiophen-3-y...)
Affinity DataKi:  1.11E+4nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075236([1-(2-{2-[1-(2,4-Dichloro-phenoxy)-1-methyl-ethyl]...)
Affinity DataKi:  1.20E+4nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075230([1-(2-{2-[(E)-2-(2,4-Dichloro-phenyl)-vinyl]-benzo...)
Affinity DataKi:  1.24E+4nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM50075247({1-[2-(2-{[(E)-2,4-Dichloro-phenylimino]-methyl}-b...)
Affinity DataKi:  1.26E+4nMAssay Description:Functional Neuropeptide Y receptor type 1 antagonism was evaluated by its ability to reverse NPY induced inhibition of forskolin-stimulated cyclic AM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 51 total ) | Next | Last >>
Jump to: